Bioengineering Process Technician
About the job
- A Bachelor of Science or equivalent degree in chemical engineering or a related discipline is required.
- Ability to read and follow standard operating procedures and regulations.
- Safety-minded, disciplined workmanship and flexibility in work hours.
- Ability to learn new skills, concepts, and tasks as required.
- Operate semi-automated equipment in a clean room for pilot production.
- Perform wafer processing, including cleaning, coating, lithography, dicing, and packaging.
- Prepare and handle hazardous chemical reagents.
- Read and follow standard operating procedures.
- Observe, document, and report on processes and problems.
- Collaborate closely with other team members and engineers.
- Train other personnel.
- Adhere to and enforce strict safety guidelines.
- Experience in clean room and laboratory operations.
- Familiarity with microelectronics or medical device manufacturing technologies.
- Detail orientation, ability to learn quickly, respond to feedback, and communicate clearly.
- Excellent written and spoken communication skills.
About the company
Centrillion Technologies develops tools for genomic studies, including sequencing, bioinformatics, and a new generation of DNA chips designed for high-density, high-quality probes that work with sequencing. Its products include ATOM, a high-throughput detection system, and VirusHunter MVP, a pathogen-detection assay, along with sequencing and droplet digital PCR services for researchers and drug discovery groups. It differentiates itself by offering integrated genomics hardware, assays, and services with DNA chips optimized for large-scale analysis that complement sequencing workflows. Its goal is to enable broad, scalable genomic studies to accelerate drug discovery, personalized medicine, and molecular diagnostics.
Company Size
51-200
Company Stage
Series B
Total Funding
$24.3M
Headquarters
Palo Alto, California
Founded
2009
Get referred to Centrillion Technologies
See people who can refer or advise you
Simplify's Take
What believers are saying
- September 2026 site updates show active product marketing and service availability.
- Centrillion’s August 2026 AI messaging targets genome, cell, and tissue data buyers.
- The platform keeps multiple revenue paths: research chips, diagnostics, and sequencing services.
What critics are saying
- VirusHunter MVP remains only through Molecular Vision Laboratories as of August 2026.
- Centrillion shows no fresh 2025-2026 financing, suggesting constrained commercial scale.
- Illumina, Thermo Fisher, and Oxford Nanopore can crush adoption if chip volumes lag.
What makes Centrillion Technologies unique
- Centrillion’s September 2026 chips combine 50,000-2 million variants with sequencing workflows.
- VirusHunter pairs pathogen detection and whole-genome sequencing on ATOM and QuadCore chips.
- The company still owns a rare integrated stack: chips, assays, and clinical-lab services.
Help us improve and share your feedback! Did you find this helpful?